These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 3744290)

  • 1. [Hepatic GOT and GPT activities in patients with various liver diseases--especially alcoholic liver disease].
    Takahashi A; Sekiya C; Yazaki Y; Ono M; Sato H; Hasebe C; Ishikawa Y; Okuno K; Yamada M; Namiki M
    Hokkaido Igaku Zasshi; 1986 May; 61(3):431-6. PubMed ID: 3744290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic transaminase activity in alocholic liver disease.
    Matloff DS; Selinger MJ; Kaplan MM
    Gastroenterology; 1980 Jun; 78(6):1389-92. PubMed ID: 7372058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldehyde dehydrogenase (E.C. 1.2.1.3) in chronic alcoholic liver diseases.
    Nilius R; Zipprich B; Krabbe S
    Hepatogastroenterology; 1983 Aug; 30(4):134-6. PubMed ID: 6629303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of release of hepatic enzymes in various liver diseases. II. Altered activity ratios of GOT to GPT in serum and liver of patients with liver diseases.
    Miyake S
    Acta Med Okayama; 1979 Oct; 33(5):343-58. PubMed ID: 160182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
    Spech HJ; Liehr H; Mitschke H
    Z Gastroenterol; 1983 Nov; 21(11):651-9. PubMed ID: 6659631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic relevance of the De Ritis quotient and gamma-glutamyltransferase in alcoholic liver parenchyma damage].
    Kilger B; Baumgarten R; Fengler JD; Bartke D
    Z Arztl Fortbild (Jena); 1986; 80(10):405-6. PubMed ID: 2875568
    [No Abstract]   [Full Text] [Related]  

  • 7. The SGOT/SGPT ratio--an indicator of alcoholic liver disease.
    Cohen JA; Kaplan MM
    Dig Dis Sci; 1979 Nov; 24(11):835-8. PubMed ID: 520102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SGOT/SGPT ratio in alcoholic liver disease.
    Alves PS; Camilo EA; Correia JP
    Acta Med Port; 1981; 3(4):255-60. PubMed ID: 7331882
    [No Abstract]   [Full Text] [Related]  

  • 9. The mechanism of the release of hepatic enzymes in various liver diseases. 1. Alterations in cytoplasmic and mitochondrial enzyme activities in serum.
    Miyake S
    Acta Med Okayama; 1979 Aug; 33(4):287-304. PubMed ID: 227231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of hyaluronate receptor (CD44) in alcoholic liver disease.
    Urashima S; Tsutsumi M; Ozaki K; Tsuchishima M; Shimanaka K; Ueshima Y; Takase S
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):34S-38S. PubMed ID: 10803777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The SGOT/SGPT ratio in the diagnosis of alcoholic hepatitis].
    Penso NC; Mota RA
    G E N; 1985; 39(4):268-70. PubMed ID: 3939518
    [No Abstract]   [Full Text] [Related]  

  • 12. Glutathione S-transferase in alcoholic fatty liver.
    Iizuka T; Sato T; Sugimoto M
    Arukoru Kenkyuto Yakubutsu Ison; 1991 Oct; 26(5):428-46. PubMed ID: 1772380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of an intravenous infusion of ethanol on serum enzymes and lipids in patients with alcoholic liver disease.
    Nishimura M; Hasumura Y; Takeuchi J
    Gastroenterology; 1980 Apr; 78(4):691-5. PubMed ID: 7353755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of type III procollagen peptide in sera of patients with liver cancer].
    Yamauchi M; Nakayama H; Fukuzawa K; Nakajima H; Takahara M; Nakahara M; Kawase H; Watanabe Y; Kimura K; Kitahara T
    Gan No Rinsho; 1984 Jun; 30(7):785-90. PubMed ID: 6086978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
    Sorbi D; Boynton J; Lindor KD
    Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between pyridoxal 5'-phosphate deficiency and aminotransferase levels in alcoholic hepatitis.
    Diehl AM; Potter J; Boitnott J; Van Duyn MA; Herlong HF; Mezey E
    Gastroenterology; 1984 Apr; 86(4):632-6. PubMed ID: 6698365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic hepatitis: indicators of disease activity].
    Masevich TsG; Ermolaeva LG
    Ter Arkh; 2000; 72(2):17-8. PubMed ID: 10717917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol and the liver. Recent developments in preclinical and clinical research. Overview.
    Lieber CS
    Recent Dev Alcohol; 1984; 2():93-102. PubMed ID: 6233639
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative versus absolute carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with acute alcoholic hepatitis.
    Halm U; Tannapfel A; Mössner J; Berr F
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1614-8. PubMed ID: 10549992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.